Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.
GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
1don MSN
Shetty, his 54-year-old wife and 28-year-old daughter have lived in their apartment on Matharpacady Road, Mazgaon, Byculla, ...
Malay Mail on MSN5d
GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in MalaysiaGlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ... As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.As of 7th Oct,2024, the GSK Pharma Share Price on NSE closed ...
Teva Pharmaceutical Industries Ltd. ADR-0.76% $19.75B ...
GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...
After hours: 4 October at 19:59 GMT-4 ...
As of , had a $0.0 market capitalization, putting it in the percentile of companies in the industry. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. ’s ...
is Rs 1385.05 Glaxosmithkline Pharmaceuticals Ltd, incorporated in the year 1924, has its registered office in GSK House, Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030, 91-022-24959595 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback